132 related articles for article (PubMed ID: 24352898)
41. Nevus-associated melanomas: clinicopathologic features.
Shitara D; Nascimento MM; Puig S; Yamada S; Enokihara MM; Michalany N; Bagatin E
Am J Clin Pathol; 2014 Oct; 142(4):485-91. PubMed ID: 25239415
[TBL] [Abstract][Full Text] [Related]
42. Principles of dermatoscopy of pigmented skin lesions.
Stolz W; Semmelmayer U; Johow K; Burgdorf WH
Semin Cutan Med Surg; 2003 Mar; 22(1):9-20. PubMed ID: 12773010
[TBL] [Abstract][Full Text] [Related]
43. How good are US dermatologists at discriminating skin cancers? A number-needed-to-treat analysis.
Wilson RL; Yentzer BA; Isom SP; Feldman SR; Fleischer AB
J Dermatolog Treat; 2012 Feb; 23(1):65-9. PubMed ID: 21756146
[TBL] [Abstract][Full Text] [Related]
44. Effect of health care delivery models on melanoma thickness and stage in a university-based referral center: an observational pilot study.
Swetter SM; Soon S; Harrington CR; Chen SC
Arch Dermatol; 2007 Jan; 143(1):30-6. PubMed ID: 17224539
[TBL] [Abstract][Full Text] [Related]
45. Early detection of thick melanomas in the United States: beware of the nodular subtype.
Demierre MF; Chung C; Miller DR; Geller AC
Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
[TBL] [Abstract][Full Text] [Related]
46. Difference between real and perceived power of dermoscopical methods for detection of malignant melanoma.
Schiffner R; Wilde O; Schiffner-Rohe J; Stolz W
Eur J Dermatol; 2003; 13(3):288-93. PubMed ID: 12804992
[TBL] [Abstract][Full Text] [Related]
47. A process modelling approach to assess the impact of teledermatology deployment onto the skin tumor care pathway.
Duong TA; Lamé G; Zehou O; Skayem C; Monnet P; El Khemiri M; Boudjemil S; Hirsch G; Wolkenstein P; Jankovic M
Int J Med Inform; 2021 Feb; 146():104361. PubMed ID: 33348274
[TBL] [Abstract][Full Text] [Related]
48. The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in France.
Durbec F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Domissy-Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A; Grange F
Arch Dermatol; 2010 Mar; 146(3):240-6. PubMed ID: 20231493
[TBL] [Abstract][Full Text] [Related]
49. Melanomas in renal transplant recipients.
Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
[TBL] [Abstract][Full Text] [Related]
50. [Melanoma in the Strasbourg University Hospital. A 30-year study].
Lipsker D; Heid E; Grosshans E; Cribier B
Ann Dermatol Venereol; 1998 Apr; 125(4):241-6. PubMed ID: 9747259
[TBL] [Abstract][Full Text] [Related]
51. Risk factors for thick melanoma among veterans: A cross-sectional study.
Hartman RI; La J; Chang MS; Cheng D; Do N; Brophy M; Fillmore NR
J Am Acad Dermatol; 2021 Jun; 84(6):1766-1769. PubMed ID: 33422630
[No Abstract] [Full Text] [Related]
52. The role of general practitioners in diagnosis of cutaneous melanoma: a population-based study in France.
Grange F; Barbe C; Mas L; Granel-Brocard F; Lipsker D; Aubin F; Velten M; Dalac S; Truchetet F; Michel C; Mitschler A; Arnoult G; Buemi A; Dalle S; Reuter G; Bernard P; Woronoff AS; Arnold F
Br J Dermatol; 2012 Dec; 167(6):1351-9. PubMed ID: 22834687
[TBL] [Abstract][Full Text] [Related]
53. Teledermatology as a means to improve access to inpatient dermatology care.
Sharma P; Kovarik CL; Lipoff JB
J Telemed Telecare; 2016 Jul; 22(5):304-10. PubMed ID: 26377123
[TBL] [Abstract][Full Text] [Related]
54. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist.
Pennie ML; Soon SL; Risser JB; Veledar E; Culler SD; Chen SC
Arch Dermatol; 2007 Apr; 143(4):488-94. PubMed ID: 17438181
[TBL] [Abstract][Full Text] [Related]
55. Variation in the depth of excision of melanoma: A survey of US physicians.
DeFazio JL; Marghoob AA; Pan Y; Dusza SW; Khokhar A; Halpern A
Arch Dermatol; 2010 Sep; 146(9):995-9. PubMed ID: 20644028
[TBL] [Abstract][Full Text] [Related]
56. [An economic analysis of presurgical teledermatology in patients with nonmelanoma skin cancer].
Ferrándiz L; Moreno-Ramírez D; Ruiz-de-Casas A; Nieto-García A; Moreno-Alvarez P; Galdeano R; Camacho FM
Actas Dermosifiliogr; 2008 Dec; 99(10):795-802. PubMed ID: 19091219
[TBL] [Abstract][Full Text] [Related]
57. Are we seeing the effects of public awareness campaigns? A 10-year analysis of Breslow thickness at presentation of malignant melanoma in the South West of England.
Armstrong A; Powell C; Powell R; Hallam N; Taylor J; Bird J; Sarran C; Oliver D
J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):324-30. PubMed ID: 24434052
[TBL] [Abstract][Full Text] [Related]
58. A retrospective comparison between preoperative and postoperative Breslow depth in primary cutaneous melanoma: how preoperative shave biopsies affect surgical management.
Saco M; Thigpen J
J Drugs Dermatol; 2014 May; 13(5):531-6. PubMed ID: 24809875
[TBL] [Abstract][Full Text] [Related]
59. The Care Coordination Home Telehealth (CCHT) rural demonstration project: a symptom-based approach for serving older veterans in remote geographical settings.
Luptak M; Dailey N; Juretic M; Rupper R; Hill RD; Hicken BL; Bair BD
Rural Remote Health; 2010; 10(2):1375. PubMed ID: 20518592
[TBL] [Abstract][Full Text] [Related]
60. Cutaneous melanoma: public health approach to early detection.
Weinstock MA
Dermatol Ther; 2006; 19(1):26-31. PubMed ID: 16405567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
